Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)
Scope of the report
The report titled "Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)" provides an in-depth analysis of global aortic aneurysm repair market with major focus on more prevalent endovascular abdominal aortic aneurysm repair. The report also provides detailed analysis of aortic aneurysm market in major regions like the US, Europe and Asia-Pacific. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). Further, key players of the industry such as Endologix, Medtronic, Gore Medical products and Cook Medical are also profiled in the report.
- Endovascular Abdominal Aortic Aneurysm Repair (EVAR)
- Thoracic Endovascular Aortic Aneurysm (TEVAR)
- The US
- European Union
- Asia Pacific
- Endologix, Inc.
- Medtronic Inc.
- Cook Medical
- Gore Medical Products
Aortic aneurysm is a general term used for enlargement for aorta which can lead to serious complications as it weakens the walls of the aorta. An aneurysm can develop anywhere along aorta but it mostly occurs in the section running through abdomen (abdominal aneurysms) and chest (thoracic aneurysms). Traditionally, open surgical repair of aneurysm was the only viable treatment option. In due course of time, more advanced minimally invasive Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) or thoracic EVAR (TEVAR) has evolved.
Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) or Endovascular stent grafting is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA) or thoracic aortic aneurysm, the procedure then specifically termed TEVAR (thoracic endovascular aortic/aneurysm repair).
Cases of aortic aneurysm have been growing at a rapid pace globally, majority being cases of abdominal aortic aneurysms. Some of the factors driving growth of the treatment market such as EVAR and TEVAR are rising geriatric population, increasing healthcare expenditure and shift from traditional to Minimally Invasive Surgeries (MIS). However, factors such as risk of complications associated with the treatment, legal and regulatory risk and global economic instability are posing challenge to industry's growth. Major trends prevailing in the industry are mergers and acquisitions, next-generation EVAR devices and dominance of infrarenal disease cases.